Ongoing Research Studies
Compensation is providing for participation
Compensation is providing for participation
NON-TREATMENT STUDIES
Depression Study
Currently recruiting Nonsmokers and Cigarette Smokers with Major Depression to participate in a brain imaging study. You may be eligible if you are between the age of 18-55, meet criteria for major depression , and are not currently using elicit drugs. If you smoke cigarettes, this is not a smoking cessation study. This study DOES NOT involve the administration of medication.
Chronic Pain - Prescription Opioid Study
This primary purpose of this study is to examine the effects that chronic pain and long-term prescription opioid use has on emotional and cognitive (e.g. attention and memory) processes. This is a brief study involving 2-3 visits. No treatment is provided, but participants do receive compensation.
TREATMENT STUDIES
Translational Neuropsychopharmacology Research (Smoking Cessation Study)
This study will examine the effects of combining Varenicline (VRN) and N-acetylcysteine (NAC) on neural circuitry function and treating nicotine addiction. Healthy adult nicotine dependent cigarette smokers interested in quitting will be randomized to one of four PBO-controlled conditions for 4 weeks: 1) VRN+NAC, 2) VRN+PBO, 3) NAC+PBO or 4) PBO+PBO. Following 1 week of medication, participants will be contingently reinforced for 3 days of smoking abstinence and be scanned using functional magnetic resonance imaging (fMRI) during a resting state and a cue-reactivity (CR) task. Participants will be followed over the next 3 weeks of treatment and clinical variables will be assessed. ClinicalTrials.gov Identifier: NCT02723162
This study will examine the effects of combining Varenicline (VRN) and N-acetylcysteine (NAC) on neural circuitry function and treating nicotine addiction. Healthy adult nicotine dependent cigarette smokers interested in quitting will be randomized to one of four PBO-controlled conditions for 4 weeks: 1) VRN+NAC, 2) VRN+PBO, 3) NAC+PBO or 4) PBO+PBO. Following 1 week of medication, participants will be contingently reinforced for 3 days of smoking abstinence and be scanned using functional magnetic resonance imaging (fMRI) during a resting state and a cue-reactivity (CR) task. Participants will be followed over the next 3 weeks of treatment and clinical variables will be assessed. ClinicalTrials.gov Identifier: NCT02723162
Mindfulness Oriented Recovery Enhancement (Smoking Cessation Study)
The objective of this study is to assess the efficacy of Mindfulness Oriented Recovery Enhancement (MORE) for treating cigarette addiction.
Yoga for Smoking Cessation.
The above link will take you to Donors Cure, an external crowdfunding website.
